Stockreport

PhaseRx to Present Data at the TIDES Conference

PHASERX  (PZRX) 
US:NASDAQ Investor Relations: investor.phaserx.com/investors/default.aspx
PDF SEATTLE, April 27, 2017 /PRNewswire/ -- PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing mRNA treatments for life-threatening inherited liver disease [Read more]